Manulife (Manufacturers Life Insurance)’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.1K | Sell |
14,849
-3,743
| -20% | -$13.9K | ﹤0.01% | 2875 |
|
|
2025
Q1 | $60.1K | Buy |
18,592
+115
| +0.6% | +$371 | ﹤0.01% | 2804 |
|
|
2024
Q4 | $103K | Buy |
18,477
+56
| +0.3% | +$312 | ﹤0.01% | 2813 |
|
|
2024
Q3 | $199K | Sell |
18,421
-554
| -3% | -$5.99K | ﹤0.01% | 2672 |
|
|
2024
Q2 | $398K | Buy |
18,975
+3,850
| +25% | +$80.8K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $482K | Buy |
15,125
+180
| +1% | +$5.74K | ﹤0.01% | 2229 |
|
|
2023
Q4 | $303K | Hold |
14,945
| – | – | ﹤0.01% | 2408 |
|
|
2023
Q3 | $190K | Buy |
14,945
+2,232
| +18% | +$28.4K | ﹤0.01% | 2629 |
|
|
2023
Q2 | $230K | Buy |
12,713
+689
| +6% | +$12.5K | ﹤0.01% | 2531 |
|
|
2023
Q1 | $207K | Hold |
12,024
| – | – | ﹤0.01% | 2547 |
|
|
2022
Q4 | $267K | Sell |
12,024
-599
| -5% | -$13.3K | ﹤0.01% | 2379 |
|
|
2022
Q3 | $101K | Sell |
12,623
-451
| -3% | -$3.63K | ﹤0.01% | 2804 |
|
|
2022
Q2 | $91.3K | Buy |
13,074
+1,294
| +11% | +$9.03K | ﹤0.01% | 2936 |
|
|
2022
Q1 | $178K | Sell |
11,780
-2,054
| -15% | -$31.1K | ﹤0.01% | 2816 |
|
|
2021
Q4 | $304 | Buy |
13,834
+2,656
| +24% | +$58 | ﹤0.01% | 2596 |
|
|
2021
Q3 | $301K | Buy |
+11,178
| New | +$301K | ﹤0.01% | 2665 |
|